Álvarez PA, Cerda TF, Elizalde BCI, Huerta RS

Language: Spanish
References: 20
Page: 220-226
PDF size: 301.66 Kb.

ABSTRACT

Background: Patients with altered ankle-arm index have risk of cardiovascular events in the next 10 years (cerebral or cardiac infarction). It is known that the glycosylated hemoglobin and each of the components of the metabolic syndrome increases the cardiovascular risk.
Material and methods: We performed a cross-sectional, multicenter, population-based study in 105 individuals with metabolic syndrome recently diagnosis in four primary care centers in Mexico City. The cardiovascular risk was evaluated using ankle-arm index.
Results: We studied 105 patients. The linear correlation analysis showed simple factor of increased risk (odds ratio [OR] 3.9 [95% CI: 1.05 -14.31]) with glycosylated hemoglobin ‹ 6.5 % and with ankle-arm index ‹ 0.9. When the glycosylated hemoglobin was ‹ 6.5 or 7 there was no statistically significant difference. Correlation of the mean arterial pressure (MAP) with the ankle-arm index: OR 7.2 for mean arterial blood pressure › 88 mm Hg OR: 5.6 (95% CI: 1.43 - 23.45) and with mean arterial pressure › 100 mm Hg.
Conclusions: Cardiovascular risk increases if the glycosylated hemoglobin is less than 6.5 %, or if the mean arterial pressure is greater than 88 mm Hg, in patients with newly diagnosed metabolic syndrome.

REFERENCES

1. C Suárez, L Manzano, J Mostaza, M Cairols, et al. Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo brazo en pacientes con síndrome metabólico. Estudio MERITO I. Rev Clin Esp 2007;207(5):228-233.

2. Elisabeth Selvin, Michael W. Steffes, Hong Zhu. Glycated hemoglobin, diebates, and cardiovascular risk on no diabetics adults. N Eng J 2010;362:800-811.

3. S. Marlene Grenon, Joel Gagnon, York Hsiang. Ankle–Brachial index for assessment of peripheral arterial disease. N Eng J 2009;361:e40.

4. Clain A, Hamilton Bailey´s demonstrations of physical sing and clinical surgery. 16th, Ed Bristol, united kingdom: John Wright, 1980.

5. White C. Intermittent caudication. N Eng J Med 2007;256:1241-1250.

6. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686-693.

7. Yao ST, Hobbs JT, Irvine WT. Ankle systolic preasure measurements in arterial disease affecting the lower extremities. Br J Surg 1969;56:676-679.

8. Carlos Lahoz , Jose M Mostaza. Indice tobillo brazo: Una herramienta útil en la estratificación del riesgo cardiovascular. Rev Esp Cardio 2006;59(7):647-649.

9. Fowkes FG, The measurement Of Atherosclerotic peripheral arterial disease in epidemiological surveys. Int J epidemiol. 1998;17:248-254.

10. O´Hare AM, Katz R, Shlipak MG, Cushman M, et al. Mortality and cardiovascular risk across the ankle-arm index spectrum: result from the cardiovascular health study. Circulation 2006;113:388-393.

11. Resnick HE, Lindsay RS, McDermont MM, Devereux RB, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the strong heart study. Circulation 2004:109;733-739.

12. American Diabetes Asociation. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-3341.

13. Norberto C. Chavez Tapia, Paloma Almeda Valdes, Daniel Motola Kuba. Síndrome metabólico aspectos fisiopatológicos e importancia epidemiológica. Medica Sur México 2004;11(3):160-167.

14. William R. Hiatt, Alartair J.J. Wood, M.D. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344(21).

15. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes care 2003;26(3):575-581.

16. Aguilar Salinas CA, et al. Analisys agreement between the world healt organization criteria and national cholesterol education program III definition of the metabolic syndrome: result from a population- based survey. Diabetes Care 2003;26(5):1635.

17. Park YW et al, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1998-1994. Arch intern med 2003;163(4):427-436.

18. Alan T. Hirsch, Ziv J. Haskal, Normal R, Hertzer. ACC/AHA 2005 Guidelines for the managements Of Patients with peripheral arterial disease (lower extremity, renal, mesenteric and abdominal aortic). J Am Coll Cardiol 2006;47:e1-e192.

19. Dormandy JA, Rutherford RB. Management of peripheral arterial disease(PAD). TASC Working Group. Transatlantic inter-society consensus (TASC). J vasc surg 2000;31(1 pt 2):S1-S296.

20. González Chávez Antonio, La Valle González Fernando, Ríos González José de Jesús. Síndrome Metabólico y Enfermedad Cardiovascular. 2009. Tercera edición.